Chlorprothixene

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameChlorprothixene
Drug Alias NameChlorprothixene (BANTruxalTaractanN-714Ro-4-0403
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsMental Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1962/03/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsMental Disorders

Other Information

ATC CodeN05AF03